Zota Health Care Limited (NSE:ZOTA)
India · Delayed Price · Currency is INR 1,230.00
+86.70 (7.58%)
Jun 3, 2026, 3:29 PM IST
Zota Health Care Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -739.36 | -563.98 | -143.48 | -57.73 | 89.08 |
Depreciation & Amortization | 824.53 | 430.5 | 200.15 | 118.73 | 35.89 |
Other Amortization | - | 1.46 | 0.7 | 0.84 | 0.83 |
Loss (Gain) From Sale of Assets | - | 0.08 | - | - | - |
Stock-Based Compensation | 29.02 | 5.95 | 3.49 | - | - |
Other Operating Activities | -89.05 | 26.21 | -0.9 | 1 | -12.17 |
Change in Accounts Receivable | -330.16 | -132.58 | -302.62 | -52.95 | -94.76 |
Change in Inventory | -869.55 | -519.18 | -119.78 | -128.41 | -7.71 |
Change in Accounts Payable | 621.96 | 87.95 | 379.93 | 215.96 | 49.78 |
Change in Other Net Operating Assets | -291.65 | 163.95 | -77.33 | -117.5 | 72.4 |
Operating Cash Flow | -844.25 | -499.64 | -59.84 | -20.06 | 133.32 |
Capital Expenditures | -1,129 | -459.78 | -167.1 | -124.99 | -32.48 |
Sale of Property, Plant & Equipment | - | 0.11 | - | 11.38 | - |
Sale (Purchase) of Intangibles | - | - | 1.02 | - | - |
Investment in Securities | -2,095 | -496.54 | 27.69 | 253.03 | -248.44 |
Other Investing Activities | 89 | 34.34 | 9.37 | 7.77 | 12.67 |
Investing Cash Flow | -3,136 | -921.86 | -129.03 | 147.04 | -266.52 |
Short-Term Debt Issued | 217.46 | - | 146.77 | - | - |
Long-Term Debt Issued | 13.75 | 49.95 | - | - | - |
Total Debt Issued | 231.21 | 49.95 | 146.77 | - | - |
Short-Term Debt Repaid | - | -140.67 | - | - | - |
Long-Term Debt Repaid | -554.61 | -217.2 | -152.09 | -76.34 | -16.54 |
Total Debt Repaid | -554.61 | -357.87 | -152.09 | -76.34 | -16.54 |
Net Debt Issued (Repaid) | -323.4 | -307.93 | -5.32 | -76.34 | -16.54 |
Issuance of Common Stock | 5,937 | 1,511 | 208.81 | - | 187 |
Common Dividends Paid | -30.64 | -27.41 | -25.85 | -37.74 | -25.16 |
Other Financing Activities | -683.57 | 271.52 | 10.12 | -24.74 | -2.57 |
Financing Cash Flow | 4,899 | 1,448 | 187.76 | -138.81 | 142.73 |
Foreign Exchange Rate Adjustments | 0.01 | 0.01 | 0 | -0 | -0.01 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | - | - |
Net Cash Flow | 919.55 | 26.14 | -1.1 | -11.84 | 9.53 |
Free Cash Flow | -1,974 | -959.42 | -226.94 | -145.05 | 100.84 |
Free Cash Flow Margin | -36.64% | -32.75% | -12.57% | -10.31% | 7.68% |
Free Cash Flow Per Share | -59.95 | -35.18 | -8.85 | -5.76 | 4.05 |
Cash Interest Paid | 173.61 | 106.82 | 41.92 | 24.74 | 2.57 |
Cash Income Tax Paid | 114.65 | 34.82 | 15.3 | 21.4 | 37.35 |
Levered Free Cash Flow | -1,712 | -806.88 | -242.83 | -148.02 | 78.14 |
Unlevered Free Cash Flow | -1,603 | -750.79 | -216.59 | -132.48 | 79.75 |
Change in Working Capital | -869.4 | -399.85 | -119.8 | -82.91 | 19.71 |